← Eichor
Condition: Ded Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Ded

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Effects of 3% Trehalose Ophthalmic Solution on Corneal Epithelial Barrier Function
Phase 4 · 1 location(s) · Southern California College of Optometry at Marshall B. Ketc · NCT06655441Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesity
Phase N/A · 1 location(s) · Attikon Hospital · NCT07605572Supplementary Kelulut Honey Therapy in Juvenile Open-Angle Glaucoma: Effects on IL-6, RNFL and Dry Eye
Phase 4 · 4 location(s) · Universiti Sains Malaysia · NCT07396441Randomized Single Center Study to Evaluate Tolerability, Symptoms, and Visual Functional Outcomes With the Use of OTC Lu
Phase 4 · 1 location(s) · Andover Research Eye Institute · NCT07676084Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of DED in Patients Undergoing Cataract Surgery
NA · 1 location(s) · Vance Thompson Vision · NCT07155057TRYPTYR as a Treatment for Patients With Dry Eye Disease (DED)
Phase 4 · 1 location(s) · NYU Langone Health · NCT07732010A Multicenter, Open-Label Study to Evaluate Perioperative Treatment of Dry Eye With Miebo® in Subjects Undergoing LASIK
Phase 4 · 4 location(s) · Vance Thompson Vision · NCT07650708A Clinical Study Evaluating Licaminlimab for Dry Eye Disease
Phase 2/Phase 3 · 14 location(s) · Oculis · NCT07548632Phase III Clinical Study of Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease
Phase 3 · 1 location(s) · Lunan Better Pharmaceutical Co., LTD. · NCT06879782BriTer Eyez Moisture Vue™ On-Demand Disposable Moisture Chamber
NA · 1 location(s) · University of Rochester · NCT07430735An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants W
Phase 2 · 24 location(s) · Dompé Farmaceutici S.p.A · NCT07503886Proteomics Analysis of Human Tears in the Diagnosis and Management of Dry Eye Disease
NA · 1 location(s) · The Hong Kong Polytechnic University · NCT07175909SYSTANE® PRO vs. MIEBO™ in Dry Eye Disease
Phase 4 · 4 location(s) · Indiana University · NCT07243275Clinical Investigation Between the Topical Administration of a Tear Substitute With Ancillary Medicinal Substance and Hy
NA · 2 location(s) · FB Vision S.p.A · NCT07412860A Study on the Correlation Between Tear Iron Levels and the Severity of Dry Eye Disease.
Phase N/A · 1 location(s) · Shanghai Changzheng Hospital · NCT07363824Role of Corneal Nerves in Dry Eye Disease
Phase N/A · 1 location(s) · Daniela Nosch · NCT06841471New Preservative-free Combination of Trehalose, Sodium Hyaluronate and N-acetyl-aspartyl-glutamate (NAAGA) in Dry Eye
Phase 4 · 1 location(s) · Laboratoires Thea · NCT06903741Impact of Tixel Treatment on Symptoms and Signs in Patients With Dry Eye Disease
NA · 1 location(s) · Aston University · NCT06615453The Effect of 0.1% Topical Ciclosporin A for 12-weeks on the Eye Surface Immune Cells in Dry Eyes
NA · 1 location(s) · The University of New South Wales · NCT06898853Dose-Finding Study of HUC1-394 in Participants With Dry Eye Disease
Phase 2 · 1 location(s) · Huons Co., Ltd. · NCT07656688Upper Punctal Plug Occlusion in Previous Lower Punctal Occlusion.
NA · 1 location(s) · Universidad Autonoma de Nuevo Leon · NCT07571330Telemedicine Evaluation of Dry Eye Disease Using a Portable Automatic Ocular Surface Imaging Device (PAOSID)
Phase N/A · 1 location(s) · Chen Wei · NCT06984549
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.